2005
DOI: 10.1378/chest.128.6.3799
|View full text |Cite
|
Sign up to set email alerts
|

The Effects of Pulmonary Rehabilitation in the National Emphysema Treatment Trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
76
0
5

Year Published

2006
2006
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 175 publications
(92 citation statements)
references
References 16 publications
3
76
0
5
Order By: Relevance
“…Data from other centers showed a mean improvement in 6MWD of 70-190 feet [5,14,16,17]. Mean improvement in 6MWD among patients in our study was greater, at 263.8 feet.…”
Section: Discussionsupporting
confidence: 42%
See 1 more Smart Citation
“…Data from other centers showed a mean improvement in 6MWD of 70-190 feet [5,14,16,17]. Mean improvement in 6MWD among patients in our study was greater, at 263.8 feet.…”
Section: Discussionsupporting
confidence: 42%
“…The reason for this greater improvement in 6MWD compared to that demonstrated by other studies is not clear. A possible explanation is that our patients had never undergone PR, and we know from the National Emphysema Treatment Trial that benefits of PR are significantly greater in patients without prior rehabilitation experience [17]. Another possible explanation is the open floor plan of our center.…”
Section: Discussionmentioning
confidence: 98%
“…Maximal exercise capacity was assessed by Wmax and VO 2 peak using an incremental symptom-limited cycle ergometer test and compared with normal values [18]. A change exceeding 10 W was considered as MCID [25]. QF was assessed using an isometric handheld dynamometer (Microfet; Biometrics, Almere, the Netherlands) attached to a knee pendicular bank.…”
Section: Methodsmentioning
confidence: 99%
“…The benefits of PR have been extensively reported in patients with chronic obstructive pulmonary disease (COPD), with the assumption that the recommendations are applicable to subjects with other lung diseases [4,5]. Benefits of PR in COPD patients are reported in view of decreased dyspnoea, increased exercise endurance, improved HRQL and reduced healthcare costs [5][6][7][8][9]. However, data supporting PR in patients with ILD are scarce and the effects of PR in patients with ILD are largely unknown.…”
Section: Introductionmentioning
confidence: 99%